Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endothelial tight junction (TJ) complex is a specialized multiprotein structure located at the apical-lateral membrane of endothelial cells, primarily responsible for regulating paracellular permeability and maintaining the vascular barrier [1, 2]. It consists of transmembrane proteins such as claudins (notably claudin-5 in the brain), occludin, and junctional adhesion molecules (JAMs), which are anchored to the actin cytoskeleton by cytoplasmic scaffolding proteins like zonula occludens (ZO-1, ZO-2, ZO-3) [4, 7, 14]. This complex is critical for the integrity of the blood-brain barrier (BBB) and other vascular beds, preventing the uncontrolled passage of solutes, pathogens, and inflammatory cells into tissues [11, 15]. In various diseases, including sepsis, cancer metastasis, and neurodegeneration, the TJ complex is disrupted, leading to edema and tissue damage [7, 18, 20]. Conversely, therapeutic strategies aim to either stabilize these junctions to treat vascular leak or transiently open them to facilitate the delivery of macromolecular drugs across barriers like the BBB [3, 5, 8]. The regulation of this complex involves intricate signaling pathways, including Rho GTPases and various kinases, which modulate the assembly and tension of the junctional proteins [2, 17]. Understanding and targeting the endothelial tight junction complex remains a pivotal area of research for improving drug delivery and managing vascular-related pathologies [5, 21].
Modulation of paracellular permeability through the regulation of transmembrane protein interactions and cytoskeletal anchoring [3, 5, 17].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial tight junction complex (TJ complex).